Published 4 days ago • loading... • Updated 4 days ago

This IBD 50 Stock, Up 90% In 2025, Is Winning Against Cancer

As the former BeiGene gears up to battle AbbVie and J&J, shares of the new BeOne Medicines haven't been this high in four years.

As the former BeiGene gears up to battle AbbVie and J&J, shares of the new BeOne Medicines haven't been this high in four years.

4 days ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right1Center0Last Updated3 days agoBias Distribution

100% Right

100% Right

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Investor's Business Daily broke the news in 4 days ago on Friday, October 3, 2025.

Sources are mostly out of (0)